Methods: Thirty New Zealand Wistar albino rabbits weighing between 2750 and 3000 grams were used in the study and divided into three groups. In the first (control) group, normal saline (0.09% NaCl); in the second group, silver nitrate (0.5%); and in the third group, chlorhexidine gluconate (0.04%) was administered intrathraceally. Thirty days after the procedure, the tracheobronchial and parenchymal changes in the subjects were evaluated histopathologically. Tracheobronchial changes were evaluated with respect to tracheal pathology whereas peribronchial lymphocytic infiltration and parenchymal changes were evaluated with respect to interstitial lymphocytic infiltration, hemorrhage-edema, fibrosis and pneumonitis.
Results: The rate of interstitial lymphocytic infiltration was higher in the chlorhexidine gluconate group than in the control group, and the rates of fibrosis and fibrin accumulation were higher in the silver nitrate group than in the control group. No statistically significant differences in other parameters were found between the groups.
Conclusion: The results of the study indicate that chlorhexidine gluconate (0.04%) has minimal negative effects on the rabbit lung and tracheobronchial mucosa and is a more reliable agent than silver nitrate.
Recently, chlorhexidine gluconate (Chx-Glu) has been a common preference in general surgery procedures, and its efficiency has been proven.[6,7] It has been reported to be safe in surgery for intraabdominal and/or liver hydatid cysts, while it has not been used in surgery for pulmonary hydatid cysts. However, before its use in such operations, it must be ensured that this agent does not impair the lungs and/or bronchial parenchyma.
This experimental study was initially planned to determine the effects of Chx-Glu on rabbit lungs. Silver nitrate, another agent of frequent use was also tested in the study and thus, the study aimed to determine the effects of silver nitrate (AgNO3) and Chx-Glu administered to the tracheobronchial system, on the lungs and bronchi of the rabbits.
Before the administration of agents, each animal was anaesthetized with xylazine 10 mg/kg and ketamine HC 20-30 mg/kg intramuscular (im.). Then, a 1 cm vertical incision was performed. The muscles were retracted by blunt dissection, and the cervical trachea was reached. Using an insulin injector, air was aspirated between the tracheal rings and 0.2 ml of the agent was injected. Finally, the muscles and the skin were sutured en-bloc (Fig. 1). After the procedure, 2.2 mg/kg of carprofen were given daily for three days as analgesic.
Fig 1: Intratracheal application of scolicidal agents, schematic view.
The rabbits were sacrificed with 200 mg/kg pentothal administration 30 days after the procedure. Samples from the animals were obtained and were embedded into 10% formaldehyde. The sampling was taken from three different segments of the distal trachea and pulmonary parenchyma of each animal. For histopathological evaluation, the paraffin blocks of the samples were sliced into sections of 4-μm thickness, and the sections were stained with hematoxylin-eosin. Parenchymal changes (Hemorrhage-edema, interstitial lymphocytic infiltration, pneumonitis, fibrin accumulation and fibrosis) were semi-quantitatively evaluated between + and +++ (mild +, moderate ++, severe +++); tracheobronchial epithelial and tracheobronchial changes (Peribronchial lymphocytic infiltration) were evaluated as 1 follicle +, 2 follicles ++, 3 and more follicles +++ (Fig. 2) by a pathologist (Table 1). To determine the rate of fibrosis in the parenchyma, Mason’s trichrome was used to stain the samples and the avidin-biotin peroxidase method was applied to tracheal biopsy specimens.
Table 1: Histopathological results of tracheobronchial alterations
Statistical analysis
Statistical Package for Social Sciences (SPSS) for
Windows 15.0 version (SPSS, Chicago, Illinois, USA)
was used for statistical evaluation. The data were
evaluated using Chi-square, Fisher’s exact and Kruskal-
Wallis tests. The data were expressed as the mean ±
standard deviation. The value p<0.05 was considered to
be significant.
Evaluation of parenchymal alterations for hemorrhage-edema revealed no statistically significant differences between the groups, although hemorrhageedema was more common in the AgNO3 a nd C hx-Glu groups than it was in the control group. The difference for interstitial lymphocytic infiltration between the groups was statistically significant. The Chx-Glu group was affected more than the control group (p=0.038), while the difference between the AgNO3 group and the control group was not statistically significant (Table 2, Fig. 3).
Table 2: Histopathological results of parenchymal alterations
The difference in the rate of pneumonitis between the groups was not statistically significant, while there was a higher rate of positivity for pneumonitis in the AgNO3 and Chx-Glu groups. For fibrin accumulation, there was a statistically significant difference between the groups. While the AgNO3 group was affected more than the control group (p=0.039), the difference between the control and Chx-Glu groups was not statistically significant (Fig. 4). The AgNO3 group had a higher rate of fibrosis than the control group (p=0.033); however, the rates of fibrosis in the Chx-Glu and control groups were not statistically significantly different.
Chx-Glu is an antiseptic agent with a broad spectrum of activity against gram-positive and gram-negative bacteria and fungi.[1,6] Recent studies have reported successful results on the use of Chx-Glu as a scolicidal agent in the surgery for intraabdominal hydatid cyst. In one study, Chx-Glu at a concentration of 0.04% was shown to kill all of the protoscolexes in five minutes.[6,7] Use of such a potent agent may reduce recurrence rates of pulmonary hydatid cysts. However, the literature reveals few studies on this issue. Thus the effects of Chx-Glu on the lungs are not clearly known.[9] This study aimed to determine the efficacy of the use of Chx-Glu in thoracic surgery procedures. In the study, the effects of Chx-Glu on the lungs were studied. Additionally, AgNO3, an agent of frequent use in thoracic surgery, was studied of which its effects on the lungs are not clearly known.
Orito et al,[9] in a preliminary study administering Chx-Glu directly into the trachea, observed cyanosis and dyspnea developing in the animals. Although they claimed injecting the agent into the left main bronchus only, the small bronchial structures of rats and administration of the agent at high concentrations may have caused the cyanosis and dyspnea. Neither cyanosis nor dyspnea were observed after the injection of the chemical agents in our study.
In our study, Chx-Glu was used at a concentration of 0.04%, two and a half times the minimum concentration used in the study by Orito et al.[9] The pathological evaluation of the specimens showed that the group that was administered Chx-Glu significantly differed from the control group only for interstitial lymphocytic infiltration. Similar to our findings, in the study by Orito et al.[9] the group that was injected with Chx-Glu at a concentration of 0.01% showed mild congestion, while the groups that received Chx-Glu at concentrations of 0.1% and 1% showed moderate and severe intraalveolar hemorrhage and congestion. In a case reported by Hirata and Kurokawa,[10] accidental oral intake of 5% Chx-Glu resulted in development of acute respiratory distress syndrome (ARDS) and death of the patient. This indicates the importance of dose adjustment. In our study, the Chx-Glu group did not significantly differ from the control group for fibrosis, pneumonitis, and fibrin accumulation. In the light of these findings, it was thought that at a concentration of 0.04%, Chx-Glu did not cause a significant damage in the lungs suggesting ARDS.
In the AgNO3 group, the rates of fibrosis development and fibrin accumulation were significantly higher than those of the control group. The rates of intraalveolar hemorrhage in both groups were also higher than those of the control group. However, the differences were not statistically significant. In the light of these results, it can be said that Chx-Glu is less toxic than AgNO3.
Recurrence is still one of the major problems in pulmonary hydatid cyst.[11] To minimize the rate of the recurrence, there are ongoing investigations for ideal scolicidal agents. Despite several studies on this issue, the concentrations used in some of these studies, and the time and degree of their efficiency are provided in table 3.[4,6,7,12,13] Table 3 shows that, Chx-Glu has been found to be the most effective scolicidal agent. Surgeons frequently start the procedure upon injection of the scolicidal agent into the cyst before the scolicidal agent shows its full effect. This reduces the efficiency of the agent used. Considering these, an agent of full efficacy that would act in a relatively shorter time will obviously reduce operating time as well as recurrence rates.
In conclusion, our results have shown that at a concentration of 0.04%, Chx-Glu is less toxic than AgNO3 on the lungs, which is negligible. Lower toxicity and higher availability of Chx-Glu compared to other scolicidal agents are its important advantages. Even at low concentrations, it acts in a shorter time with full efficacy and is a safe scolicidal agent as previously reported. Thus, we believe Chx-Glu may be used to reduce the recurrence rates of pulmonary hydatid cysts.
Table 3: Studies with scolicidal agents in terms of efficiency and duration
Acknowledgement
We thank to Ziynet Çınar (Assistant Professor in
Cumhuriyet University, Medical School, Department of
Biostatistics, Sivas, Turkey) for statistical analysis.
Declaration of conflicting interests
The authors declared no conflicts of interest with respect
to the authorship and/or publication of this article.
Funding
This work was supported by the Cumhuriyet University
Scientific Research Foundation (CUBAP T-321).
1) Topcu O, Kuzu I, Karayalcin K. Effects of peritoneal lavage
with scolicidal agents on survival and adhesion formation in
rats. World J Surg 2006;30:127-33.
2) Sahin E, Enön S, Cangir AK, Kutlay H, Kavukçu S,
Akay H, et al. Single-stage transthoracic approach for right
lung and liver hydatid disease. J Thorac Cardiovasc Surg
2003;126:769-73.
3) Tor M, Atasalihi A, Altuntas N, Sulu E, Senol T, Kir A, et al.
Review of cases with cystic hydatid lung disease in a tertiary
referral hospital located in an endemic region: a 10 years’
experience. Respiration 2000;67:539-42.
4) Ciftci IH, Esme H, Sahin DA, Solak O, Sezer M, Dilek ON.
Effect of octenidine dihydrochloride on viability of protoscoleces
in hepatic and pulmonary hydatid diseases. J Natl
Med Assoc 2007;99:674-7.
5) Nadir A, Kaptanoglu M. Surgical management of pulmonary
hydatidosis. ANZ J Surg 2007;77:800-1.
6) Puryan K, Karadayi K, Topcu O, Canbay E, Sumer Z, Turan
M, et al. Chlorhexidine gluconate: an ideal scolicidal agent
in the treatment of intraperitoneal hydatidosis? World J Surg
2005;29:227-30.
7) Topcu O, Sumer Z, Tuncer E, Aydin C, Koyuncu A. Efficacy
of chlorhexidine gluconate during surgery for hydatid cyst.
World J Surg 2009;33:1274-80.
8) Topcu O, Kuzu I, Karayalcin K. Effects of peritoneal lavage
with scolicidal agents on survival and adhesion formation in
rats. World J Surg 2006;30:127-33.
9) Orito K, Hashida M, Hirata K, Kurokawa A, Shirai M,
Akahori F. Effects of single intratracheal exposure to
chlorhexidine gluconate on the rat lung. Drug Chem Toxicol
2006;29:1-9.
10) Hirata K, Kurokawa A. Chlorhexidine gluconate ingestion
resulting in fatal respiratory distress syndrome. Vet Hum
Toxicol 2002;44:89-91.
11) Kayaalp C, Balkan M, Aydin C, Ozgurtas T, Tanyuksel M,
Kirimlioglu V, et al. Hypertonic saline in hydatid disease.
World J Surg 2001;25:975-9.